Vertically integrated clinics, services, products and intellectual property
Standing firmly on three scalable pillars of clinics, products and intellectual property, we are perfectly positioned to take advantage of the major opportunities presented by changing markets and demographics.
Our advanced clinics focus on integrative oncology and regenerative medicine. With over 80% of cancer patients seeking complementary treatments, we go beyond the three basic protocols of surgery, radiotherapy and chemotherapy. That’s why we’ve combined the latest integrative methods with evidence- based treatments that are patient-focused, rather than disease- focused.
We’ve developed and purchased valuable intellectual property in proprietary and licensed diagnostic technology, treatment protocols, nutraceutical formulations and pharma-delivery systems.
We’ve established a growing pharmaceutical and supplement manufacturing division with strategically placed facilities in Australia, Malaysia and soon in the USA. Our new compounding facility, the largest regional GMP/TGA-certified facility in Johor, Malaysia, launches in 2016, enabling us to customise certain products on demand, based on individual needs.